News
Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital ...
Onconetix, Inc. Cincinnati, OH, April 30, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital ...
Cincinnati, OH, April 30, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq ...
Cincinnati, OH, April 30, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq ...
Onconetix, Inc., a pharmaceutical company with a market capitalization of just $490,000, is facing potential delisting from The Nasdaq Stock Market LLC due to its inability to maintain the minimum ...
(MENAFN- GlobeNewsWire - Nasdaq) Cincinnati, OH, April 30, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the“Company”) announced that it received a Staff delisting letter from The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback